0001104659-22-073897.txt : 20220623
0001104659-22-073897.hdr.sgml : 20220623
20220623160634
ACCESSION NUMBER: 0001104659-22-073897
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220621
FILED AS OF DATE: 20220623
DATE AS OF CHANGE: 20220623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mills C Randal
CENTRAL INDEX KEY: 0001370939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39577
FILM NUMBER: 221035475
MAIL ADDRESS:
STREET 1: 18366 CALLE STELLINA
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001708527
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474790334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
BUSINESS PHONE: 240-247-1143
MAIL ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
4
1
tm2219201-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-21
0
0001708527
AZIYO BIOLOGICS, INC.
AZYO
0001370939
Mills C Randal
C/O AZIYO BIOLOGICS, INC.
12510 PROSPERITY DRIVE, SUITE 370
SILVER SPRING
MD
20904
1
1
0
0
Interim President and CEO
Stock Option (Right to Buy)
6.39
2022-06-21
4
A
0
273767
0
A
2032-06-20
Class A Common Stock
273767
273767
D
Stock Option (Right to Buy)
6.39
2022-06-21
4
A
0
182511
0
A
2032-06-20
Class A Common Stock
182511
182511
D
The option vests and becomes exercisable as to one-third of the underlying shares upon the day following the expiration of the Interim Period (as defined in the Reporting Person's Employment Agreement dated June 21, 2022). The remaining two-thirds of the underlying shares vest and become exercisable, with respect to 25% of such shares, on June 21, 2023, and, with respect to 75% of such shares, in twelve equal quarterly installments thereafter, beginning on September 21, 2023, subject to the Reporting Person's continuous employment with the Issuer through the applicable vesting date.
The option vests and becomes exercisable in four equal installments upon the Issuer's achievement of a share price equal to or greater than $12.50, $17.00, $25.00 and $37.00, in each case determined based on twenty consecutive days of trading at or above the applicable threshold, subject to the Reporting Person's continuous employment with the Issuer through the applicable vesting date.
/s/ Jeffrey Hamet, Attorney-in-Fact for C Randal Mills
2022-06-23